Hemophilia Gene Therapy Market - Size, Growth Dynamics & Forecast (2024-2032) The treatment for Hemophilia, a challenging inherited bleeding disorder, has historically involved frequent, costly intravenous injections of clotting factors. However, we are entering a new era of medicine where a one-time treatment may offer a near-cure.
Gene therapy—the process of introducing a functional copy of the deficient clotting factor gene directly into a patient’s...
0 Shares
9 Views
0 Reviews